Annotation Detail

Information
Associated Genes
CTLA4
Associated Variants
CTLA4 MUTATION
CTLA4 MUTATION
Associated Disease
melanoma
Source Database
DisGeNET
Description
In melanoma patients treated with an immune checkpoint therapy, high viral defense signature expression in tumors significantly associates with durable clinical response and DNMTi treatment sensitizes to anti-CTLA4 therapy in a pre-clinical melanoma model.
Pubmed
26317466
Section of the abstract supporting the evidence
ALL_TEXT_3/3
Number of the section of the abstract supporting the evidence
3
Number of the sentence supporting the evidence
6
Original source reporting the Gene Disease association
BeFree,CTD_human,GAD,LHGDN
DisGENET score for the Gene Disease association
0.136892866374025
Drugs